Annual Current Ratio
29.27
+10.66+57.28%
31 December 2023
Summary:
Akero Therapeutics annual current ratio is currently 29.27, with the most recent change of +10.66 (+57.28%) on 31 December 2023. During the last 3 years, it has risen by +8.57 (+41.40%). AKRO annual current ratio is now -11.11% below its all-time high of 32.93, reached on 31 December 2018.AKRO Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
17.25
-7.64-30.70%
30 September 2024
Summary:
Akero Therapeutics quarterly current ratio is currently 17.25, with the most recent change of -7.64 (-30.70%) on 30 September 2024. Over the past year, it has dropped by -3.00 (-14.81%). AKRO quarterly current ratio is now -49.87% below its all-time high of 34.41, reached on 30 June 2019.AKRO Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.3% | -14.8% |
| 3 y3 years | +41.4% | +83.1% |
| 5 y5 years | -11.1% | -22.7% |
AKRO Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +280.1% | -42.7% | +150.0% |
| 5 y | 5 years | -11.1% | +280.1% | -42.7% | +150.0% |
| alltime | all time | -11.1% | +919.9% | -49.9% | +150.0% |
Akero Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 17.25(-30.7%) |
| June 2024 | - | 24.89(-17.4%) |
| Mar 2024 | - | 30.12(+2.9%) |
| Dec 2023 | 29.27(+57.3%) | 29.27(+44.5%) |
| Sept 2023 | - | 20.25(-32.0%) |
| June 2023 | - | 29.78(+42.9%) |
| Mar 2023 | - | 20.84(+12.0%) |
| Dec 2022 | 18.61(+141.7%) | 18.61(+24.3%) |
| Sept 2022 | - | 14.97(+117.0%) |
| June 2022 | - | 6.90(-9.2%) |
| Mar 2022 | - | 7.60(-1.3%) |
| Dec 2021 | 7.70 | 7.70(-18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | 9.42(-34.4%) |
| June 2021 | - | 14.35(-43.1%) |
| Mar 2021 | - | 25.23(+21.9%) |
| Dec 2020 | 20.70(+40.5%) | 20.70(-16.6%) |
| Sept 2020 | - | 24.81(+127.8%) |
| June 2020 | - | 10.89(-28.5%) |
| Mar 2020 | - | 15.23(+3.4%) |
| Dec 2019 | 14.73(-55.3%) | 14.73(-34.0%) |
| Sept 2019 | - | 22.32(-35.1%) |
| June 2019 | - | 34.41(+17.0%) |
| Mar 2019 | - | 29.41(-10.7%) |
| Dec 2018 | 32.93(+1047.4%) | 32.93 |
| Dec 2017 | 2.87 | - |
FAQ
- What is Akero Therapeutics annual current ratio?
- What is the all time high annual current ratio for Akero Therapeutics?
- What is Akero Therapeutics annual current ratio year-on-year change?
- What is Akero Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Akero Therapeutics?
- What is Akero Therapeutics quarterly current ratio year-on-year change?
What is Akero Therapeutics annual current ratio?
The current annual current ratio of AKRO is 29.27
What is the all time high annual current ratio for Akero Therapeutics?
Akero Therapeutics all-time high annual current ratio is 32.93
What is Akero Therapeutics annual current ratio year-on-year change?
Over the past year, AKRO annual current ratio has changed by +10.66 (+57.28%)
What is Akero Therapeutics quarterly current ratio?
The current quarterly current ratio of AKRO is 17.25
What is the all time high quarterly current ratio for Akero Therapeutics?
Akero Therapeutics all-time high quarterly current ratio is 34.41
What is Akero Therapeutics quarterly current ratio year-on-year change?
Over the past year, AKRO quarterly current ratio has changed by -3.00 (-14.81%)